Related Experiment Video
Updated: Jun 13, 2026

New Features in Visual Dynamics 3.0
Published on: August 9, 2024
Conference scene: DGVS spring conference 2009
1Department of Medicine II, University of Munich, Marchioninistrasse 15, 81377 Munich, Germany. fkolligs@med.uni-muenchen.de
The 3rd annual German Society for Gastroenterology conference focused on translational gastrointestinal oncology, emphasizing personalized medicine. Key discussions included biomarkers, response prediction, and integrating these into clinical trials for improved patient outcomes.
Area of Science:
- Gastroenterology
- Oncology
- Translational Research
Background:
- The 3rd annual DGVS Spring Conference convened in Berlin, Germany, on May 8-9, 2009.
- The central theme was 'translational gastrointestinal oncology: towards personalized medicine and individualized therapy'.
- The conference aimed to advance the understanding and application of personalized medicine in gastrointestinal oncology.
Purpose of the Study:
- To summarize key findings and discussions from the DGVS Spring Conference.
- To highlight advancements in biomarkers, response prediction, and clinical trial integration in gastrointestinal oncology.
- To provide an overview of personalized medicine approaches in the field.
Main Methods:
- Focus on presentations concerning biomarkers for diagnosis, screening, and surveillance of colorectal cancer.
- Review of discussions on molecular therapy targets and response prediction in clinical oncology.
- Examination of the development and integration of molecular imaging and translational research in clinical trial design.
Main Results:
- Significant focus on the role of biomarkers in diagnosing and managing gastrointestinal cancers.
- Exploration of molecular targets and predictive markers for therapeutic response.
- Emphasis on integrating biomarker data into clinical trials for personalized treatment strategies.
Conclusions:
- Translational research is crucial for advancing personalized medicine in gastrointestinal oncology.
- Biomarkers play a pivotal role in tailoring cancer therapies and improving patient outcomes.
- The integration of biomarkers into clinical trials is essential for developing individualized treatment plans.
More Related Videos
06:28A Networked Desktop Virtual Reality Setup for Decision Science and Navigation Experiments with Multiple Participants
Published on: August 26, 2018
09:40Imaging G-protein Coupled Receptor (GPCR)-mediated Signaling Events that Control Chemotaxis of Dictyostelium Discoideum
Published on: September 20, 2011
Related Concept Videos
IP3/DAG Signaling Pathway
International Nursing Organizations II
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
pV-Diagrams
Formal Charges
Frequency of Spring-Mass System
Consider a block on a spring on a frictionless surface. There...
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...